Back

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023-04-19 infectious diseases Title + abstract only
View on medRxiv
Show abstract

BackgroundEmpagliflozin has been proposed as a treatment for COVID-19 on the basis of its anti-inflammatory, metabolic and haemodynamic effects. MethodsIn this randomised, controlled, open-label trial, several possible treatments are compared with usual care in patients hospitalised with COVID-19. Eligible and consenting adults were randomly allocated in a 1:1 ratio to either usual standard of care alone or usual standard of care plus empagliflozin 10mg once daily for 28 days or until discharge...

Predicted journal destinations

1
BMJ Open
553 training papers
Top 8% 16.6%
2
The Lancet Respiratory Medicine
16 training papers
#1 10.3%
3
PLOS ONE
1737 training papers
Top 64% 8.5%
4
Clinical Infectious Diseases
219 training papers
Top 8% 4.7%
5
BMJ
49 training papers
Top 0.2% 4.7%
6
JAMA Network Open
125 training papers
Top 4% 3.9%
7
Scientific Reports
701 training papers
Top 69% 3.6%
8
Nature Communications
483 training papers
Top 30% 3.6%
9
PLOS Medicine
95 training papers
Top 3% 2.6%
10
BMC Medicine
155 training papers
Top 9% 2.6%
11
eClinicalMedicine
55 training papers
Top 0.5% 1.8%
12
Open Forum Infectious Diseases
124 training papers
Top 7% 1.8%
13
BMC Infectious Diseases
110 training papers
Top 13% 1.5%
14
Clinical Microbiology and Infection
54 training papers
Top 4% 1.4%
15
Frontiers in Medicine
99 training papers
Top 15% 1.3%
16
Nature Medicine
88 training papers
Top 10% 1.1%
17
The Lancet Infectious Diseases
57 training papers
Top 7% 0.9%
18
eLife
262 training papers
Top 47% 0.9%
19
The Journal of Infectious Diseases
137 training papers
Top 15% 0.9%
20
The Lancet
16 training papers
Top 0.2% 0.9%
21
International Journal of Infectious Diseases
115 training papers
Top 21% 0.9%
22
Journal of Infection
64 training papers
Top 9% 0.9%
23
New England Journal of Medicine
49 training papers
Top 3% 0.9%
24
PLOS Global Public Health
287 training papers
Top 35% 0.7%
25
eBioMedicine
82 training papers
Top 15% 0.7%
26
Infectious Diseases and Therapy
18 training papers
Top 1.0% 0.7%
27
Journal of Clinical Medicine
77 training papers
Top 24% 0.7%
28
Annals of Internal Medicine
27 training papers
Top 2% 0.7%